Cargando…

Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná

OBJECTIVES: To compare the results of conventional serological tests and molecular technology (NAT, Nucleic Acid Amplification Test), identify donors in the diagnostic window period, and determine the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Madeira, Heloise Skiavine, da Silva, Claudinei Mesquita, Scapini, Neila Cristina, de Peder, Leyde Daiane, Teixeira, Jorge Juarez Vieira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233538/
https://www.ncbi.nlm.nih.gov/pubmed/34194265
http://dx.doi.org/10.1016/j.jsps.2021.04.019
_version_ 1783713874918244352
author Madeira, Heloise Skiavine
da Silva, Claudinei Mesquita
Scapini, Neila Cristina
de Peder, Leyde Daiane
Teixeira, Jorge Juarez Vieira
author_facet Madeira, Heloise Skiavine
da Silva, Claudinei Mesquita
Scapini, Neila Cristina
de Peder, Leyde Daiane
Teixeira, Jorge Juarez Vieira
author_sort Madeira, Heloise Skiavine
collection PubMed
description OBJECTIVES: To compare the results of conventional serological tests and molecular technology (NAT, Nucleic Acid Amplification Test), identify donors in the diagnostic window period, and determine the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) among the samples of blood donors blocked by serological screening. METHODS: A retrospective cross-sectional study was carried out by analyzing blood donor information contained in the database of 20 blood centers in Paraná, from January 2018 to December 2019. RESULTS: A total of 1,496 blood bags were reactive for HBV, HCV, or HIV in serological and/or NAT tests. The 20th Regional Health (RH) Unit had the greatest number of unfit individuals with altered screening for the three infections, with a prevalence of 0.70%. The lowest number of blocked blood donors occurred in the 15th RH, with a prevalence of 0.08%. The highest prevalence of HBV occurred in the 8th RH, with a reagent serology of 0.34% and a positive NAT of 0.17%. For HCV, the prevalence for reagent serology was 0.28%, while that for NAT was 0.02%, which occurred in the 20th RH. For HIV and for NAT, the prevalence of blood donors with positive serology occurred in the 20th RH, at 0.25% and 0.04%, retrospectively. The 13th RH had the highest prevalence of HIV in relation to NAT, that is, conventional serology in concomitance with NAT technology, at 0.07%. During the 2-year period, only 1 reactive donor in the 9th was found for NAT (HBV), in a diagnostic window. CONCLUSION: In Paraná’s blood centers, the inability to donate due to HBV, HCV, and HIV, occurred mainly in initial donors, men, those with >8 years of education, aged 16–45 years, married, and O positive. The most affected regions were located in the west and northwest of Paraná. Most of the results showed a discrepancy between the methodologies used.
format Online
Article
Text
id pubmed-8233538
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82335382021-06-29 Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná Madeira, Heloise Skiavine da Silva, Claudinei Mesquita Scapini, Neila Cristina de Peder, Leyde Daiane Teixeira, Jorge Juarez Vieira Saudi Pharm J Original Article OBJECTIVES: To compare the results of conventional serological tests and molecular technology (NAT, Nucleic Acid Amplification Test), identify donors in the diagnostic window period, and determine the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) among the samples of blood donors blocked by serological screening. METHODS: A retrospective cross-sectional study was carried out by analyzing blood donor information contained in the database of 20 blood centers in Paraná, from January 2018 to December 2019. RESULTS: A total of 1,496 blood bags were reactive for HBV, HCV, or HIV in serological and/or NAT tests. The 20th Regional Health (RH) Unit had the greatest number of unfit individuals with altered screening for the three infections, with a prevalence of 0.70%. The lowest number of blocked blood donors occurred in the 15th RH, with a prevalence of 0.08%. The highest prevalence of HBV occurred in the 8th RH, with a reagent serology of 0.34% and a positive NAT of 0.17%. For HCV, the prevalence for reagent serology was 0.28%, while that for NAT was 0.02%, which occurred in the 20th RH. For HIV and for NAT, the prevalence of blood donors with positive serology occurred in the 20th RH, at 0.25% and 0.04%, retrospectively. The 13th RH had the highest prevalence of HIV in relation to NAT, that is, conventional serology in concomitance with NAT technology, at 0.07%. During the 2-year period, only 1 reactive donor in the 9th was found for NAT (HBV), in a diagnostic window. CONCLUSION: In Paraná’s blood centers, the inability to donate due to HBV, HCV, and HIV, occurred mainly in initial donors, men, those with >8 years of education, aged 16–45 years, married, and O positive. The most affected regions were located in the west and northwest of Paraná. Most of the results showed a discrepancy between the methodologies used. Elsevier 2021-06 2021-04-24 /pmc/articles/PMC8233538/ /pubmed/34194265 http://dx.doi.org/10.1016/j.jsps.2021.04.019 Text en © 2021 Published by Elsevier B.V. on behalf of King Saud University. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Madeira, Heloise Skiavine
da Silva, Claudinei Mesquita
Scapini, Neila Cristina
de Peder, Leyde Daiane
Teixeira, Jorge Juarez Vieira
Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná
title Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná
title_full Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná
title_fullStr Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná
title_full_unstemmed Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná
title_short Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná
title_sort correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis b virus, hepatitis c and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the state of paraná
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233538/
https://www.ncbi.nlm.nih.gov/pubmed/34194265
http://dx.doi.org/10.1016/j.jsps.2021.04.019
work_keys_str_mv AT madeiraheloiseskiavine correlationbetweenserologyandnucleicacidamplificationtestinblooddonorswhoarereactiveforhepatitisbvirushepatitiscandhumanimmunodeficiencyvirusandevaluationoftheepidemiologicalprofileofinfectedpeopleinbloodcentersinthestateofparana
AT dasilvaclaudineimesquita correlationbetweenserologyandnucleicacidamplificationtestinblooddonorswhoarereactiveforhepatitisbvirushepatitiscandhumanimmunodeficiencyvirusandevaluationoftheepidemiologicalprofileofinfectedpeopleinbloodcentersinthestateofparana
AT scapinineilacristina correlationbetweenserologyandnucleicacidamplificationtestinblooddonorswhoarereactiveforhepatitisbvirushepatitiscandhumanimmunodeficiencyvirusandevaluationoftheepidemiologicalprofileofinfectedpeopleinbloodcentersinthestateofparana
AT depederleydedaiane correlationbetweenserologyandnucleicacidamplificationtestinblooddonorswhoarereactiveforhepatitisbvirushepatitiscandhumanimmunodeficiencyvirusandevaluationoftheepidemiologicalprofileofinfectedpeopleinbloodcentersinthestateofparana
AT teixeirajorgejuarezvieira correlationbetweenserologyandnucleicacidamplificationtestinblooddonorswhoarereactiveforhepatitisbvirushepatitiscandhumanimmunodeficiencyvirusandevaluationoftheepidemiologicalprofileofinfectedpeopleinbloodcentersinthestateofparana